We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Novel IV Catheter with Multi-Access Blood Control Reduces Risk of Bloodborne Pathogen Exposure

By HospiMedica International staff writers
Posted on 12 Oct 2023

Getting intravenous (IV) access is a key part of infusion therapy, and healthcare professionals are still at risk for needlestick injuries. More...

These injuries can expose them to infections from bloodborne pathogens. Research has indicated that fully automatic safety devices are twice as effective as semi-automatic push-button shields and three times more effective than manually operated sliding shields in preventing needlestick injuries. Now, a new IV catheter with multi-access blood control and fully automatic safety features aims to offer enhanced protection to clinicians whenever they access the catheter hub.

B. Braun Medical (Melsungen, Germany) has launched its new Introcan Safety 2 IV Catheter which comes with multi-access blood control. This new catheter is part of B. Braun's continuing efforts to develop catheters that minimize needlestick injuries. What sets this catheter apart is that it not only provides automatic protection against needlestick injuries but also includes a feature that protects from blood exposure each time the catheter hub is accessed. This lowers the chance of exposure to bloodborne pathogens throughout the IV procedure.

Another concern besides needlestick injuries is the risk of blood exposure from spillage when accessing the catheter hub. Catheters with blood control features have been proven to significantly cut down on the risk of blood exposure as well as the time and effort needed for cleanup. Survey results also suggest possible cost savings in terms of time and supplies needed for cleaning up blood spills. The Introcan Safety 2 Catheter's multi-access blood control feature is designed to work repeatedly, reducing the risk of blood exposure and spillage during the entire IV process.

"Appropriate device selection is key to achieving successful PIVC outcomes," said Chad Laity, Director of Marketing, Vascular Access, IV Systems and Securement. "The newly launched Introcan Safety 2 IV Catheter with Multi-Access Blood Control provides clinicians with another option when choosing the right device for their patients. When combined with our Peripheral Advantage Program, our technology and solutions are designed to facilitate the best possible outcomes around vascular access care."

Related Links:
B. Braun Medical 


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Captivator EMR Device
Captivator Endoscopic Mucosal Resection Device
New
Medical Cart
Medical Carts
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.